Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Apollo Endosurgery Inc (APEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7363
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Apollo Endosurgery Inc (Apollo Endo), formerly Lpath Inc, is a medical technology company that designs, develops and commercializes medical devices used for the treatment of obesity. The company’s product portfolio comprises endo-bariatric products such as Orbera Intragastric Balloon System and OverStitch endoscopic suturing system; and Lap-Band system for laparoscopic bariatric surgeries. These surgical and non-surgical interventional devices are also used in procedures that address or repair a variety of gastrointestinal defects. Apollo Endo’s products are used by bariatric surgeons, general surgeons and gastroenterologists. It has a manufacturing facility in the Coyol Free Trade Zone in Alajuela, Costa Rica. Apollo Endo is headquartered in Austin, Texas, the US.

Apollo Endosurgery Inc (APEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apollo Endosurgery Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 10
Venture Financing 12
Apollo Endosurgery Secures USD50 Million from Athyrium Opportunities Fund 12
Apollo Endosurgery Raises US$60.7 Million In Series C Financing 13
Apollo Endosurgery Raises US$47.6 Million In New Round Of Financing 14
Partnerships 15
Lpath Enters Into Licensing Agreement With Provista Diagnostics For Cancer Diagnostics 15
Apollo Endosurgery Enters into Distribution Agreement with Slater Endoscopy 16
Merger 17
Lpath and Apollo Endosurgery Merges 17
Equity Offering 18
Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 18
Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 20
Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 21
Apollo Endosurgery Inc – Key Competitors 23
Apollo Endosurgery Inc – Key Employees 24
Apollo Endosurgery Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 08, 2018: Apollo Endosurgery reports second quarter 2018 results 26
May 03, 2018: Apollo Endosurgery Reports First Quarter 2018 Results 27
Mar 01, 2018: Apollo Endosurgery Reports Fourth Quarter and Full Year 2017 Results 28
Oct 26, 2017: Apollo Endosurgery Reports Third Quarter 2017 Results 30
Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results 32
Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 34
May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 35
Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 36
Corporate Communications 38
May 31, 2018: Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors 38
Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Apollo Endosurgery Inc, Medical Equipment, Key Facts, 2017 2
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Deals By Market, 2012 to YTD 2018 8
Apollo Endosurgery Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 10
Apollo Endosurgery Secures USD50 Million from Athyrium Opportunities Fund 12
Apollo Endosurgery Raises US$60.7 Million In Series C Financing 13
Apollo Endosurgery Raises US$47.6 Million In New Round Of Financing 14
Lpath Enters Into Licensing Agreement With Provista Diagnostics For Cancer Diagnostics 15
Apollo Endosurgery Enters into Distribution Agreement with Slater Endoscopy 16
Lpath and Apollo Endosurgery Merges 17
Apollo Endosurgery Raises USD23.7 Million in Public Offering of Shares 18
Apollo Endosurgery to Raise up to USD16 Million in Public Offering of Shares 20
Apollo Endosurgery Raises USD36 Million in Public Offering of Shares 21
Apollo Endosurgery Inc, Key Competitors 23
Apollo Endosurgery Inc, Key Employees 24
Apollo Endosurgery Inc, Other Locations 25
Apollo Endosurgery Inc, Subsidiaries 25

List of Figures
Apollo Endosurgery Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Apollo Endosurgery Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Apollo Endosurgery Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Apollo Endosurgery Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Apollo Endosurgery Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Apollo Endosurgery Inc (APEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pronto Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary Pronto Diagnostics Ltd (PDL) is a medical device company that offers molecular diagnostic products and services. The company develops, produces and distributes SNP-detection kits providing assays for detecting polymorphisms in DNA sequences with genetic diseases and predisposition to disease …
  • DNO ASA (DNO):企業の財務・戦略的SWOT分析
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It operates its oil and gas producing assets lo …
  • Wahl Clipper Corporation:企業の戦略・SWOT・財務情報
    Wahl Clipper Corporation - Strategy, SWOT and Corporate Finance Report Summary Wahl Clipper Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Red Hat Inc:企業の戦略的SWOT分析
    Red Hat Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Centre for Drug Design and Discovery:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • The Boston Consulting Group:企業の戦略・SWOT・財務分析
    The Boston Consulting Group - Strategy, SWOT and Corporate Finance Report Summary The Boston Consulting Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rush Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rush Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Connell Limited Partnership:企業の戦略・SWOT・財務情報
    Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Thrive Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Thrive Bioscience Inc (Thrive Bioscience) is a life science company that provides automated non-microbial cell culture instruments. The company’s cell culture systems provide scalable cell propagation, analytics, reproducible protocols, and complete process history documentation with the ima …
  • Checkpoint Surgical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Checkpoint Surgical Inc (Checkpoint Surgical) is a medical device company that offers neuro-protective surgical devices. The company’s products include checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators provide biphasic stimulat …
  • HSE Integrated Ltd:企業の戦略的SWOT分析
    HSE Integrated Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Apollo Commercial Real Estate Finance, Inc.:企業のM&A・事業提携・投資動向
    Apollo Commercial Real Estate Finance, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apollo Commercial Real Estate Finance, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務分析
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Reply S.p.A. (REY):企業の財務・戦略的SWOT分析
    Reply S.p.A. (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Milo Biotechnology LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Milo Biotechnology LLC (Milo) is a biotechnology company that develops novel therapies based on follistatin, a protein that increases muscle mass and strength. The company’s pipeline product includes AAV1 (based on adeno-associated virus), which is a gene therapy for the one time treatment o …
  • Delcath Systems Inc (DCTH):医療機器:M&Aディール及び事業提携情報
    Summary Delcath Systems Inc (Delcath) specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloods …
  • Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Crossject SA (ALCJ)-医療機器分野:企業M&A・提携分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company offers products which include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free injection system to develop a pipeline of supergenerics by …
  • Mount Gibson Iron Ltd:企業の戦略・SWOT・財務情報
    Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report Summary Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • United Bank Of India
    United Bank Of India - Strategy, SWOT and Corporate Finance Report Summary United Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆